{
  "title": "Leucemia de Células Plasmáticas (PCL)",
  "guid": "4C70DC80286D8D6E3368C61E",
  "filepath": "/sessions/bold-jolly-cerf/mnt/Dropbox/- Esquemas/- Entidades clínicas/Neumología/UTD. Leucemia de Células Plasmáticas-2025-1.smmx",
  "root": {
    "id": "0",
    "parent": "-1",
    "text": "Leucemia de Células\nPlasmáticas (PCL)",
    "guid": "cg-zukLH-mgmJdtAVSn51g",
    "children": [
      {
        "id": "1",
        "parent": "0",
        "text": "- Definición y Tipos",
        "guid": "",
        "children": [
          {
            "id": "2",
            "parent": "1",
            "text": "› Forma rara y agresiva de Mieloma Múltiple (MM) ★",
            "guid": "SUEzKhOz7JkcHvtaSpXSXw",
            "children": []
          },
          {
            "id": "3",
            "parent": "1",
            "text": "› Caracterizada por células plasmáticas circulantes en sangre periférica (detectables en frotis convencional)",
            "guid": "fgkpqWh05Ih7OGNIL_XTVw",
            "children": []
          },
          {
            "id": "4",
            "parent": "1",
            "text": "› Subtipos",
            "guid": "SF7aimusVaAnjr_Ke_XpgQ",
            "children": [
              {
                "id": "5",
                "parent": "4",
                "text": "◊ PCL Primaria: Originada de novo",
                "guid": "X4zzBBVgogZHm40oVyafGw",
                "children": []
              },
              {
                "id": "6",
                "parent": "4",
                "text": "◊ PCL Secundaria: Transformación leucémica de MM preexistente",
                "guid": "dy50IlFj6SlX1keCKvLs6A",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "7",
        "parent": "0",
        "text": "- Epidemiología",
        "guid": "HdTFqQBD1PBeW7MGD-R5Yw",
        "children": [
          {
            "id": "8",
            "parent": "7",
            "text": "› Trastorno raro de células plasmáticas",
            "guid": "QwvPWQSBjkZlDnM6FJZfuw",
            "children": []
          },
          {
            "id": "9",
            "parent": "7",
            "text": "› Incidencia histórica: 60-70% PCL primaria [1, 2]",
            "guid": "ZC9jVB2L8Ogjx_0zLXCWfw",
            "children": []
          },
          {
            "id": "10",
            "parent": "7",
            "text": "› Tendencia actual: Distribución más equitativa (~50/50) [1, 2]",
            "guid": "MT_dgj_m-I14BmjeL0kHKw",
            "children": [
              {
                "id": "11",
                "parent": "10",
                "text": "◊ Posible ↑ incidencia PCL secundaria\n(reflejo de mejor supervivencia en MM) [1, 2]",
                "guid": "KFvdFXM-zCZfPtqCcLq3oA",
                "children": []
              }
            ]
          },
          {
            "id": "12",
            "parent": "7",
            "text": "› Progresión a PCL secundaria: 1-4% de pacientes con MM [1, 3, 4]",
            "guid": "XushxgbNmkxssKEhPngUyw",
            "children": []
          },
          {
            "id": "13",
            "parent": "7",
            "text": "› Edad media al\ndiagnóstico:",
            "guid": "bbjQWByrUGMzaVZ-MMSfsQ",
            "children": [
              {
                "id": "14",
                "parent": "13",
                "text": "◊ PCL Primaria: 55 años",
                "guid": "HC48UjRMLkkVnrPmE1ywdA",
                "children": []
              },
              {
                "id": "15",
                "parent": "13",
                "text": "◊ PCL Secundaria: 66 años",
                "guid": "BbAXcm10-2g-T51cI4TdGw",
                "children": []
              }
            ]
          },
          {
            "id": "16",
            "parent": "7",
            "text": "› Distribución: Global, todos los orígenes étnicos",
            "guid": "ISzeqRh3ybhFWv9tBVxB_g",
            "children": []
          },
          {
            "id": "17",
            "parent": "7",
            "text": "› Incidencia reportada (USA/Europa): ~4 casos / 10, 000,000 personas/año [5, 6]",
            "guid": "NgO6oWki_KAyzNh9Z0OYIw",
            "children": [
              {
                "id": "18",
                "parent": "17",
                "text": "◊ Probablemente subestimada (cambio criterios diagnósticos)",
                "guid": "KQn1LirTQVsWjJ9OUWXSQw",
                "children": []
              }
            ]
          },
          {
            "id": "19",
            "parent": "7",
            "text": "› Mayor incidencia en población Negra\nAmericana vs Blanca (similar a MM) [5] ★",
            "guid": "HhINgXXLedBCIInjfP0vRw",
            "children": []
          },
          {
            "id": "20",
            "parent": "7",
            "text": "› Datos **SEER**\n(**1973-2004**) [5]:",
            "guid": "fJkUHC7RKwQ7dUQSGMdQbg",
            "children": [
              {
                "id": "21",
                "parent": "20",
                "text": "◊ 291 pacientes PCL identificados (vs ~49,000 MM)",
                "guid": "Yx1ZTVET9_gsJADjaM1wvw",
                "children": []
              },
              {
                "id": "22",
                "parent": "20",
                "text": "◊ Incidencia relativa PCL: 0.6%",
                "guid": "PojzYGpznj8MUk3aLEHDuQ",
                "children": []
              },
              {
                "id": "23",
                "parent": "20",
                "text": "◊ Sin diferencias significativas vs MM por sexo, edad o raza",
                "guid": "Bx7uoj-7pFldBmNqKEvNTA",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "24",
        "parent": "0",
        "text": "- Presentación Clínica",
        "guid": "",
        "children": [
          {
            "id": "25",
            "parent": "24",
            "text": "› Síntomas\nsuperpuestos con MM:",
            "guid": "WDNuESJhYtctqA9KDjcosg",
            "children": [
              {
                "id": "26",
                "parent": "25",
                "text": "◊ Disfunción renal",
                "guid": "C4RfeGB058d1esDVNI5Upg",
                "children": []
              },
              {
                "id": "27",
                "parent": "25",
                "text": "◊ Hipercalcemia ★",
                "guid": "C0gpIgwHYCMF9CbpKVo2ow",
                "children": []
              },
              {
                "id": "28",
                "parent": "25",
                "text": "◊ Lesiones óseas líticas ★",
                "guid": "AdLZ80gUsM0mV2XqfmvuDw",
                "children": []
              },
              {
                "id": "29",
                "parent": "25",
                "text": "◊ Dolor óseo",
                "guid": "duXb0WHMqf0XMz5-WgM1Hw",
                "children": []
              },
              {
                "id": "30",
                "parent": "25",
                "text": "◊ Anemia",
                "guid": "MuCh9UNXP2FC0KXecWmVVg",
                "children": []
              }
            ]
          },
          {
            "id": "31",
            "parent": "24",
            "text": "› Síntomas superpuestos\ncon otras leucemias:",
            "guid": "LcrdoE8i87kdq1kPNOnMQw",
            "children": [
              {
                "id": "32",
                "parent": "31",
                "text": "◊ Leucocitosis (Mediana 18.6 cél/microL [1])",
                "guid": "Dt6YEnqxvHldNZmPZxIGIw",
                "children": []
              },
              {
                "id": "33",
                "parent": "31",
                "text": "◊ Anemia (Mediana Hb 9.2 g/dL [1]) ★",
                "guid": "HRMfUQrdqNl1SS7WKJd-yQ",
                "children": []
              },
              {
                "id": "34",
                "parent": "31",
                "text": "◊ Trombocitopenia (Mediana plaquetas 75/microL [1]) ★",
                "guid": "a1KQoGrD76tdJdNvdpq5wg",
                "children": []
              },
              {
                "id": "35",
                "parent": "31",
                "text": "◊ Infecciones",
                "guid": "dstPz2MZ-lgf9PBleJ4pwg",
                "children": []
              },
              {
                "id": "36",
                "parent": "31",
                "text": "◊ Hepatoesplenomegalia ★ (Hepatomegalia 21%, Esplenomegalia 13% [1])",
                "guid": "Ky6rJUZMVk93ChfSIhSG9w",
                "children": []
              }
            ]
          },
          {
            "id": "37",
            "parent": "24",
            "text": "› Diagnóstico previo de MM: ~40-50% de los casos [7]",
            "guid": "KBkATA49VlB8F7wWWvmiQg",
            "children": []
          },
          {
            "id": "38",
            "parent": "24",
            "text": "› Otros hallazgos\nfrecuentes [1, 2]:",
            "guid": "UZSVsT7oYfRMYzeYf19zUQ",
            "children": [
              {
                "id": "39",
                "parent": "38",
                "text": "◊ Lesiones osteolíticas (44%)",
                "guid": "DgtVrWoOkKc0ST-UHOntvw",
                "children": []
              },
              {
                "id": "40",
                "parent": "38",
                "text": "◊ Plasmocitoma extramedular (14%)",
                "guid": "ZMBNIBF-2SMD-_PjAdNscQ",
                "children": []
              },
              {
                "id": "41",
                "parent": "38",
                "text": "◊ Linfadenopatía",
                "guid": "HFyB_HlFIrkqaus6B68SnA",
                "children": []
              },
              {
                "id": "42",
                "parent": "38",
                "text": "◊ Derrames pleurales",
                "guid": "ZAkSZAeQvql-ScxeWtRiMw",
                "children": []
              },
              {
                "id": "43",
                "parent": "38",
                "text": "◊ Déficits neurológicos (afectación SNC)",
                "guid": "aqq5Ah4-vMNTcov2FdlkJw",
                "children": []
              },
              {
                "id": "44",
                "parent": "38",
                "text": "◊ LDH y beta-2 microglobulina elevadas ★",
                "guid": "ZIsTE0p8o8g37eseDKQTXw",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "45",
        "parent": "0",
        "text": "- Características\nPatológicas",
        "guid": "",
        "children": [
          {
            "id": "46",
            "parent": "45",
            "text": "› Sangre periférica",
            "guid": "WLn6GDQFpzRnnbWhKk6PyQ",
            "children": [
              {
                "id": "47",
                "parent": "46",
                "text": "◊ Morfología: Células\nplasmáticas circulantes ★",
                "guid": "cu4JKTQA7TkprgMaAPle1g",
                "children": [
                  {
                    "id": "48",
                    "parent": "47",
                    "text": "• Maduras: Ovales, citoplasma basófilo, núcleo excéntrico (\"rueda de carro\"), hof perinuclear [picture 1, picture 2]",
                    "guid": "Hg994F33Qq8d40yWAs_LAQ",
                    "children": []
                  },
                  {
                    "id": "49",
                    "parent": "47",
                    "text": "• Inmaduras: Cromatina dispersa, nucléolos prominentes, alta relación N/C",
                    "guid": "b3Yb0iHfQHkEozdyC9Kdzw",
                    "children": []
                  }
                ]
              },
              {
                "id": "50",
                "parent": "46",
                "text": "◊ Inmunofenotipo: Células clonales\n(restricción kappa o lambda)",
                "guid": "GyRjMi8OIq0TgbBrfy11lg",
                "children": [
                  {
                    "id": "51",
                    "parent": "50",
                    "text": "• Diferencias vs\nMM [9-11]:",
                    "guid": "Np7hVhHLfMpaAdfKIUmaWA",
                    "children": [
                      {
                        "id": "52",
                        "parent": "51",
                        "text": "› PCL más frecuente: CD20, CD23, CD28, CD44, CD45",
                        "guid": "MAo5jS10Y8A3Iv6AFJVMoA",
                        "children": []
                      },
                      {
                        "id": "53",
                        "parent": "51",
                        "text": "› PCL menos frecuente: CD9, CD56, CD71, CD117, HLA-DR",
                        "guid": "d_EHiG8Q6Z4hOWAAUKsBoA",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "54",
            "parent": "45",
            "text": "› Características genéticas ★",
            "guid": "IxaQ0wjXFaF6-ZFpFgSZ_A",
            "children": [
              {
                "id": "55",
                "parent": "54",
                "text": "◊ Sin anomalía única diagnóstica; frecuentes anomalías complejas (alto riesgo)",
                "guid": "PNgC2ySnlIMW_fjSWueAuw",
                "children": []
              },
              {
                "id": "56",
                "parent": "54",
                "text": "◊ Hipodiploidía/diploidía: >80% [2]",
                "guid": "Ap7XMjThRWhdt0u8chTzBQ",
                "children": []
              },
              {
                "id": "57",
                "parent": "54",
                "text": "◊ Anomalías\ncomunes [1]:",
                "guid": "VsCF4WJagy9955DUceTpEw",
                "children": [
                  {
                    "id": "58",
                    "parent": "57",
                    "text": "• del(13q) / monosomía 13 (67-85%)",
                    "guid": "EWil3BFpQT9xEl6qSAeHMg",
                    "children": []
                  },
                  {
                    "id": "59",
                    "parent": "57",
                    "text": "• del(17p) (pérdida **TP53**) (~50% PCL primaria, 75% PCL secundaria)",
                    "guid": "IzS-CUsUNnRpUSGLUz73lw",
                    "children": []
                  },
                  {
                    "id": "60",
                    "parent": "57",
                    "text": "• Anomalías Cr 1 (amp 1q21, del(1p21))",
                    "guid": "eIiaNCB0IAtn1EQ3cHmhvA",
                    "children": []
                  },
                  {
                    "id": "61",
                    "parent": "57",
                    "text": "• t(4;14) (16%)",
                    "guid": "D4UJqQkNpDdBJKNcMpuafA",
                    "children": []
                  },
                  {
                    "id": "62",
                    "parent": "57",
                    "text": "• t(14;16) (16%)",
                    "guid": "EeS52TweNMVIoDR4Try8tA",
                    "children": []
                  },
                  {
                    "id": "63",
                    "parent": "57",
                    "text": "• Mayor incidencia vs MM: t(11;14), t(14;16), monosomía 13",
                    "guid": "YMXJSF-eLUsppD1vY2Sgew",
                    "children": []
                  },
                  {
                    "id": "64",
                    "parent": "57",
                    "text": "• Similar incidencia vs MM: t(4;14)",
                    "guid": "FH9yswdbiSxVeZOAaz_4lQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "65",
                "parent": "54",
                "text": "◊ Reordenamientos **MYC**: 13-40% [1, 12, 13]",
                "guid": "abYMW1NhJFRdJOGoex6yNw",
                "children": []
              },
              {
                "id": "66",
                "parent": "54",
                "text": "◊ Otras anomalías PCL primaria: Pérdida Cr 16 (80%) [14], Cr 7 (11%) [14], Cr X (25%) [15]; Trisomía Cr 8 (43%) [9]",
                "guid": "ZMplk043QFJDJjlpB_8jnQ",
                "children": []
              }
            ]
          },
          {
            "id": "67",
            "parent": "45",
            "text": "› Aspirado y biopsia de\nmédula ósea [picture 3]",
            "guid": "GUt2xix3WvRbPhs0EdQQ-g",
            "children": [
              {
                "id": "68",
                "parent": "67",
                "text": "◊ Similar a MM: Aumento células plasmáticas monoclonales",
                "guid": "TOt6_0MSX2sCTbK2XHCEqQ",
                "children": []
              },
              {
                "id": "69",
                "parent": "67",
                "text": "◊ Infiltración extensa, alto índice proliferativo, morfología anaplásica/plasmablástica [2]",
                "guid": "TCADo0NyVhIPDB8lXgS9fA",
                "children": []
              }
            ]
          },
          {
            "id": "70",
            "parent": "45",
            "text": "› Electroforesis de proteínas e inmunofijación\n[figure 1, figure 2]",
            "guid": "f5CK11esU54swXowYFZUIA",
            "children": [
              {
                "id": "71",
                "parent": "70",
                "text": "◊ Usualmente: Producción inmunoglobulina monoclonal (suero/orina 24h)",
                "guid": "N0qA6VZlt59DuvSbS8nznA",
                "children": []
              },
              {
                "id": "72",
                "parent": "70",
                "text": "◊ Tipos Ig (frecuencia aprox.) [1]: IgG (33%), IgA (20%), IgD (3%), IgE (1%)",
                "guid": "XcFAyxk0iBs3CewxR3dNJg",
                "children": []
              },
              {
                "id": "73",
                "parent": "70",
                "text": "◊ Enfermedad de cadenas ligeras solamente: ~35%",
                "guid": "bJWsbxQuzdpClf9dUWASAg",
                "children": []
              },
              {
                "id": "74",
                "parent": "70",
                "text": "◊ No secretores: <10%",
                "guid": "YmYOLAW8OMdZXzWfe7GE8w",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "75",
        "parent": "0",
        "text": "- Diagnóstico",
        "guid": "MjOTuzSdUNMNhZXtfx8Ouw",
        "children": [
          {
            "id": "76",
            "parent": "75",
            "text": "› Evaluación diagnóstica\n[algorithm 1]",
            "guid": "d6-wPw_TSKRbj5NkQ8-z4g",
            "children": [
              {
                "id": "77",
                "parent": "76",
                "text": "◊ Sospecha en MM\n(confirmado/sospechado) con:",
                "guid": "U0Wetmqbsokh1HFeUtYpjg",
                "children": [
                  {
                    "id": "78",
                    "parent": "77",
                    "text": "• Células plasmáticas circulantes (frotis) ★",
                    "guid": "QkgGJ06V644zLH2ueZKHEA",
                    "children": []
                  },
                  {
                    "id": "79",
                    "parent": "77",
                    "text": "• LDH elevada",
                    "guid": "JPujLXbncklFXHqtArzj-Q",
                    "children": []
                  },
                  {
                    "id": "80",
                    "parent": "77",
                    "text": "• Hepatoesplenomegalia",
                    "guid": "EBv6ZHxmZt5KNDEffLGm0w",
                    "children": []
                  },
                  {
                    "id": "81",
                    "parent": "77",
                    "text": "• Derrame pleural",
                    "guid": "EJU0uAzKMH1OEbjVcvtC5Q",
                    "children": []
                  }
                ]
              },
              {
                "id": "82",
                "parent": "76",
                "text": "◊ Referencia\nurgente a experto",
                "guid": "EoZpRCdw7nVurMfYRLn8_w",
                "children": []
              },
              {
                "id": "83",
                "parent": "76",
                "text": "◊ Examen frotis sangre periférica (mínimo 100-200 células nucleadas) [8]",
                "guid": "XA4_SHwyXcVD2Qu6U73vhw",
                "children": []
              },
              {
                "id": "84",
                "parent": "76",
                "text": "◊ Citometría de flujo sangre periférica (confirmar clonalidad)",
                "guid": "DAWmaR9onx4XjaNpX0tFIA",
                "children": []
              }
            ]
          },
          {
            "id": "85",
            "parent": "75",
            "text": "› Criterios diagnósticos\n(**IMWG**) [8] ★",
            "guid": "CgRRqDliFMcyIW6uTExXzw",
            "children": [
              {
                "id": "86",
                "parent": "85",
                "text": "◊ Diagnóstico confirmado de MM [(table 1)]",
                "guid": "B_gAVWVN7FxF3t7gLPOjgw",
                "children": []
              },
              {
                "id": "87",
                "parent": "85",
                "text": "◊ ≥5% células plasmáticas en diferencial leucocitario\n(frotis manual convencional) ★",
                "guid": "XDVepQs7WY0vsId8bFFZCQ",
                "children": [
                  {
                    "id": "88",
                    "parent": "87",
                    "text": "• Basado en frotis manual, NO citometría de flujo [18]",
                    "guid": "B6HAa3nkuJtpAv_cGDb1JA",
                    "children": []
                  },
                  {
                    "id": "89",
                    "parent": "87",
                    "text": "• Umbral revisado (antes ≥20% o >2000/microL [19, 21]) basado en pronóstico similar [8, 16, 17, 22, 23]",
                    "guid": "Bq7pGDcUuLELMjgJGTVSXA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "90",
            "parent": "75",
            "text": "› Diagnóstico\ndiferencial",
            "guid": "XoWnJnne_-Fd709cOpPmbw",
            "children": [
              {
                "id": "91",
                "parent": "90",
                "text": "◊ MM (<5% CP circulantes en frotis)",
                "guid": "dhFdpiHIWxYOUdX2AhcEEA",
                "children": []
              },
              {
                "id": "92",
                "parent": "90",
                "text": "◊ Otras leucemias/linfomas (distinguir por morfología, CF/IHQ)",
                "guid": "QTD6NSXfeWBhYkkwSzVL3Q",
                "children": []
              },
              {
                "id": "93",
                "parent": "90",
                "text": "◊ Plasmocitosis reactiva policlonal (excluir por ausencia clonalidad)",
                "guid": "X0GOJxODt94XgaOsZzmOfQ",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "94",
        "parent": "0",
        "text": "- Pronóstico",
        "guid": "",
        "children": [
          {
            "id": "95",
            "parent": "94",
            "text": "› Pobre, peor que MM de alto riesgo ★",
            "guid": "eNGkOl1ggowULTIAVQcC3w",
            "children": []
          },
          {
            "id": "96",
            "parent": "94",
            "text": "› Supervivencia global (OS) media histórica: 6-11 meses [1, 5, 12, 19]",
            "guid": "aJvcGUPduXxBWFvocD2chQ",
            "children": [
              {
                "id": "97",
                "parent": "96",
                "text": "◊ OS PCL Secundaria: 2-7 meses [1]",
                "guid": "PcJyFypbW8QIdJGpRHFbMA",
                "children": []
              }
            ]
          },
          {
            "id": "98",
            "parent": "94",
            "text": "› Mejora modesta con nuevas terapias\n(HCT autólogo, agentes noveles)",
            "guid": "YXAUdROmybJdpq2MP_W7nA",
            "children": [
              {
                "id": "99",
                "parent": "98",
                "text": "◊ Datos **SEER** (**1973-2009**) [24]: OS media 12 meses en **2006-2009**",
                "guid": "DYXJkzuV_Oh6iaILA5cnOQ",
                "children": []
              }
            ]
          },
          {
            "id": "100",
            "parent": "94",
            "text": "› Modelo pronóstico (PCL primaria,\n**2006-2016**) [25]:",
            "guid": "XV5X_wjbeAEFritJHo9SNA",
            "children": [
              {
                "id": "101",
                "parent": "100",
                "text": "◊ Factores riesgo peor OS: Edad ≥60, Plaquetas ≤100x10⁹/L, CP sangre ≥20x10⁹/L",
                "guid": "LrrxYWcQdHlpxJ4RDfx_iQ",
                "children": []
              },
              {
                "id": "102",
                "parent": "100",
                "text": "◊ OS media (0, 1, 2-3 factores): 46, 27, 12 meses",
                "guid": "epQsVwFGQb11Ng4Gc2XQkQ",
                "children": []
              }
            ]
          },
          {
            "id": "103",
            "parent": "94",
            "text": "› Relación con anomalías\ngenéticas de alto riesgo [1] ★",
            "guid": "XqbESgljQAZIbNNwR0KgYw",
            "children": [
              {
                "id": "104",
                "parent": "103",
                "text": "◊ del(13), t(4;14), t(14; 16), del(17p13)",
                "guid": "TUD5ggnFL1g3gDzoCwNrmQ",
                "children": []
              }
            ]
          },
          {
            "id": "105",
            "parent": "94",
            "text": "› Impacto genético\nespecífico:",
            "guid": "NCCLHD_0zpFPdMbJFZCfkg",
            "children": [
              {
                "id": "106",
                "parent": "105",
                "text": "◊ PCL primaria con t(11;14) podría tener mejor pronóstico\n(OS media 39 vs 18 meses) [26] (Estudio **2014-2020**)",
                "guid": "U5uYQy0bdFZVhlsuYSFh1g",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "107",
        "parent": "0",
        "text": "- Tratamiento",
        "guid": "",
        "children": [
          {
            "id": "108",
            "parent": "107",
            "text": "› Evaluación\npre-tratamiento",
            "guid": "aLFxPlAP_TlkuIkQRg_JPQ",
            "children": [
              {
                "id": "109",
                "parent": "108",
                "text": "◊ Historia/Examen físico (comorbilidades, síntomas)",
                "guid": "WOt1OmpmtFlknxtxB6ZmnA",
                "children": []
              },
              {
                "id": "110",
                "parent": "108",
                "text": "◊ Estudios: Hemograma, frotis, CF sangre, Bioquímica completa (incl. LDH, B2M), FLC séricas, Electroforesis/IF (suero/orina),\nMO (aspirado/biopsia + IF + FISH), Imagenología ósea (TC/PET-TC/RM), FEVI (si necesario)",
                "guid": "UXco005juYIVouYlTAtVKg",
                "children": []
              }
            ]
          },
          {
            "id": "111",
            "parent": "107",
            "text": "› Prevención y manejo\nde complicaciones",
            "guid": "T6n7QArY9Cs_cSW8LlC_ig",
            "children": [
              {
                "id": "112",
                "parent": "111",
                "text": "◊ Síndrome Lisis Tumoral (SLT) [algorithm 2]: ★ Alto riesgo → Profilaxis/manejo agresivo (hidratación, rasburicasa/alopurinol)",
                "guid": "FDw0MQfd-Sx1k1_tYX0tsw",
                "children": []
              },
              {
                "id": "113",
                "parent": "111",
                "text": "◊ Hipercalcemia: Tratamiento según severidad (hidratación, bifosfonatos, etc.)",
                "guid": "EaMohS0TnNZsgJlMRcOzoQ",
                "children": []
              },
              {
                "id": "114",
                "parent": "111",
                "text": "◊ Otras (como en MM): Eventos esqueléticos, daño renal, infecciones, neuropatía, trombosis",
                "guid": "bQhrZzv1YBZbVFMzQKQDqw",
                "children": []
              }
            ]
          },
          {
            "id": "115",
            "parent": "107",
            "text": "› Tratamiento\ninicial",
            "guid": "aRDUbDDarmEhxWWBUcJFqg",
            "children": [
              {
                "id": "116",
                "parent": "115",
                "text": "◊ Metas: Paliativo, mejorar calidad vida, prolongar OS ★ (No curativo convencional)",
                "guid": "AOqrmgZ97pEX0g7oWdYg1Q",
                "children": []
              },
              {
                "id": "117",
                "parent": "115",
                "text": "◊ Estrategia (**European\nMyeloma Network**) [27]:",
                "guid": "cOSi63xxKllhfIdxQlvLvg",
                "children": [
                  {
                    "id": "118",
                    "parent": "117",
                    "text": "• Inicio inmediato",
                    "guid": "StTj3HcfbZYOZyDoGn7fHA",
                    "children": []
                  },
                  {
                    "id": "119",
                    "parent": "117",
                    "text": "• Según elegibilidad\nHCT autólogo:",
                    "guid": "a3abaWQyXPEtHRv3WH8G0Q",
                    "children": [
                      {
                        "id": "120",
                        "parent": "119",
                        "text": "› Elegible: Inducción (3-6 ciclos) → HCT autólogo → Mantenimiento",
                        "guid": "AfhhwU3YRqRIz56mFjSV8g",
                        "children": []
                      },
                      {
                        "id": "121",
                        "parent": "119",
                        "text": "› No elegible: Inducción (8-12 ciclos) → Mantenimiento",
                        "guid": "VbY_0T5i_pN3scOlZ1loVg",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "122",
                    "parent": "117",
                    "text": "• Considerar ensayos clínicos\n`https://clinicaltrials.gov/`",
                    "guid": "ICe9BwhxbysZIwp8CTiRcw",
                    "children": []
                  }
                ]
              },
              {
                "id": "123",
                "parent": "115",
                "text": "◊ Inducción: Regímenes basados en\n**Bortezomib** preferidos [28, 29] ★",
                "guid": "OUwdjDrob_1a-tceOjbJJw",
                "children": [
                  {
                    "id": "124",
                    "parent": "123",
                    "text": "• Opciones:",
                    "guid": "QWZej3LM5gYUDOn8MksBeg",
                    "children": [
                      {
                        "id": "125",
                        "parent": "124",
                        "text": "› VDT-PACE (más agresivo)",
                        "guid": "bz4QX3WJcW10ps04OhL0Ow",
                        "children": []
                      },
                      {
                        "id": "126",
                        "parent": "124",
                        "text": "› Dara-VRd",
                        "guid": "bKjfAwMN7iBUkdNXbqFAxA",
                        "children": []
                      },
                      {
                        "id": "127",
                        "parent": "124",
                        "text": "› VCd (CyBorD) [(table 2)]",
                        "guid": "UOY0xR1hcf0E1da2Jpx0lg",
                        "children": []
                      },
                      {
                        "id": "128",
                        "parent": "124",
                        "text": "› VTd [(table 3)]",
                        "guid": "W8RwkXyHmlsN9dzsRzsL-g",
                        "children": []
                      },
                      {
                        "id": "129",
                        "parent": "124",
                        "text": "› VRd [(table 4)]",
                        "guid": "YLn3TDsS-OMfuhLLAOG0VA",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "130",
                    "parent": "123",
                    "text": "• Evidencia: Estudios fase II [34], retrospectivos [7, 35], extrapolación MM alto riesgo",
                    "guid": "Q4RoDjjdHUcKGkXHfNCFmw",
                    "children": []
                  },
                  {
                    "id": "131",
                    "parent": "123",
                    "text": "• **Carfilzomib**: Activo (Estudio EMN12/HOVON129 [46]: KRd) pero no comparado directamente",
                    "guid": "c8WNRWUVHOU3B07CNSvr1A",
                    "children": []
                  }
                ]
              },
              {
                "id": "132",
                "parent": "115",
                "text": "◊ Trasplante (HCT)",
                "guid": "V-IC60sUOL5ndu1ORyATSw",
                "children": [
                  {
                    "id": "133",
                    "parent": "132",
                    "text": "• Autólogo: Recomendado para elegibles post-inducción ★ [7, 25, 34, 47-51]",
                    "guid": "QJ2qK1wduoYBMweGLUaJLg",
                    "children": [
                      {
                        "id": "134",
                        "parent": "133",
                        "text": "› Mejora OS vs no HCT, pero peor OS vs MM post-HCT",
                        "guid": "XyuoplXE2t4b58nyMBHdaw",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "135",
                    "parent": "132",
                    "text": "• Alogénico: Rol investigacional, considerar en ensayo clínico [49]",
                    "guid": "cyZM2yC9oKhWrlIBTuq9bA",
                    "children": [
                      {
                        "id": "136",
                        "parent": "135",
                        "text": "› Peor OS vs autólogo en PCL",
                        "guid": "HUU7A2SkLu0WJclnff8yTw",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "137",
                "parent": "115",
                "text": "◊ Mantenimiento: Recomendado **Lenalidomida** y/o **Bortezomib**\n(preferible doble si tolerado) vs observación ★",
                "guid": "H7cn0TXf3DJ-4OajYzuP3w",
                "children": [
                  {
                    "id": "138",
                    "parent": "137",
                    "text": "• Basado en cortas remisiones y extrapolación de MM",
                    "guid": "brz5egj7LGtgDBV6YoKGvw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "139",
            "parent": "107",
            "text": "› Evaluación de\nla respuesta",
            "guid": "bhBJUBcTZDwXrnKTRfJMPA",
            "children": [
              {
                "id": "140",
                "parent": "139",
                "text": "◊ Antes de cada ciclo",
                "guid": "Yiec-n8lX-ENEl-HIsVHJQ",
                "children": []
              },
              {
                "id": "141",
                "parent": "139",
                "text": "◊ Criterios **IMWG** específicos para PCL [(table 5)] [2] ★",
                "guid": "W0MaZw5FZw1QC9BTOm7DDQ",
                "children": []
              },
              {
                "id": "142",
                "parent": "139",
                "text": "◊ Meta: RC, pero no intensificar si no se logra",
                "guid": "ZApB62vzmkVqgKB5VzCOxw",
                "children": []
              },
              {
                "id": "143",
                "parent": "139",
                "text": "◊ Recaída: Definida por criterios clínicos/laboratorio [2] → Reiniciar tratamiento",
                "guid": "DLE67UEu8nomG0wzKfZ18A",
                "children": []
              }
            ]
          },
          {
            "id": "144",
            "parent": "107",
            "text": "› Tratamiento enfermedad\nrecurrente/refractaria ★",
            "guid": "JdMhaDxBFZon9ahARYpJOQ",
            "children": [
              {
                "id": "145",
                "parent": "144",
                "text": "◊ Individualizado, información limitada",
                "guid": "ciDxzSbWjuMoxdkYYN3rRw",
                "children": []
              },
              {
                "id": "146",
                "parent": "144",
                "text": "◊ Opciones:",
                "guid": "L9G7TgjR7pNDYHIGHeIEnw",
                "children": [
                  {
                    "id": "147",
                    "parent": "146",
                    "text": "• Otros regímenes MM activos",
                    "guid": "H-VSz1sO5Jlj1FDbAgzvyg",
                    "children": []
                  },
                  {
                    "id": "148",
                    "parent": "146",
                    "text": "• Retratamiento (si recaída fuera de tto)",
                    "guid": "WjREenDmsGIk0jbvNXde4Q",
                    "children": []
                  },
                  {
                    "id": "149",
                    "parent": "146",
                    "text": "• Trasplante (alogénico)",
                    "guid": "fywXb3TeB0Nv5iHuYzZZWw",
                    "children": []
                  },
                  {
                    "id": "150",
                    "parent": "146",
                    "text": "• Ensayos clínicos `https://clinicaltrials.gov/`",
                    "guid": "YNGhiFpmwmc6ZugibYLcdg",
                    "children": []
                  }
                ]
              },
              {
                "id": "151",
                "parent": "144",
                "text": "◊ Tratamientos de\ninterés específico:",
                "guid": "G5W04mCCNFUXeVJmQWjWSg",
                "children": [
                  {
                    "id": "152",
                    "parent": "151",
                    "text": "• Regímenes con **Daratumumab** (anti-CD38) [52]",
                    "guid": "HMNJ8D9u-qYG8x-DDuQ7vQ",
                    "children": []
                  },
                  {
                    "id": "153",
                    "parent": "151",
                    "text": "• **Venetoclax** (para t(11;14)+) [53-59]",
                    "guid": "ZkWJii-4-JtvwicEFhdE2A",
                    "children": []
                  },
                  {
                    "id": "154",
                    "parent": "151",
                    "text": "• Terapias celulares (CAR-T anti-BCMA): Datos limitados [60]",
                    "guid": "OIrnLjMimQoz-Ul3WHA5_g",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "155",
        "parent": "0",
        "text": "Mielograma",
        "guid": "mBtXySVMAm032p2QcJPjJw",
        "children": []
      }
    ]
  },
  "node_count": 156,
  "relations": [],
  "cross_references": [],
  "specialty": "Hematología",
  "folder": "- Entidades clínicas/Neumología",
  "filename": "UTD. Leucemia de Células Plasmáticas-2025-1",
  "id": "map_402",
  "resolved_references": []
}